Logo
P

Paratek Pharmaceuticals

339 employees

Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that advance our technology and strengthen Paratek. Our Vision To be a leading independent biopharmaceutical company providing novel life-saving products for life-threatening diseases or other public health threats.

Investor insights

Funding rounds participated in

$60M sweet spot round size

Investor type

Public Company

Basic info

Industry

Pharmaceutical Manufacturing

Sectors

Pharmaceutical Manufacturing

Date founded

1996

Funding rounds raised

Total raised

$60M

from 1 investors over 1 rounds

P

Paratek Pharmaceuticals raised $60M on February 4, 2021

Investors: CBC Group

FAQ